Glaukos announced that 200 papers published on their glaucoma product, the iStent. . We’re pleased to say that Dr. Novack was the medical writer for lead authors Dr. Thomas Samuelson and L. Jay Katz on the first one, in Ophthalmology. This demonstrates one of our principles – publications in quality journals have a long lasting benefit.
Client publishes 100th paper – PharmaLogic wrote the first one
Recent Posts
- 60 products!
- PharmaLogic to provide service to Zhaoke Ophthalmology
- Value of medical writers discussed in top journal
- Client publishes 100th paper – PharmaLogic wrote the first one
- Dr. Novack’s paper among top 100 glaucoma papers
- Unintended consequences of off-label use
- Off-label use: Article in the American Journal of Ophthalmology
Gary D. Novack, PhD, president of PharmaLogic Development
Dr. Novack speaking at ASCRS 2014
Dr. Novack talked in two symposia at the Glaucoma 360 event of the Glaucoma Research Foundation in San Francisco.
PharmaLogic sponsor a northern California bicycle riding team “Caballo Rojo
UCSC Chancellor George Blumenthal and Foundation President Ken Doctor thank Dr. Novack for his service to UCSC.
Dr. Novack on floor of California State Assembly with Assemblymember Beall (D-San Jose)
Dr. Novack addresses European Glaucoma Society on Generic Drugs
Dr. Novack with Dr. Wiley Chambers (FDA/CDER), Dr. Ellen Strahlman (CMO GSK), and Dr. Malvina Eydelman (FDA/CDRH) at the Glaucoma 360 event.
Dr. Novack speaking at International Symposium on Ocular Pharmacology and Therapeutics, Vienna, Austria
Dr. Elizabeth Moyer and Dr. Novack at ophthalmology workshop European Medicines Agency
Dr. Novack presents young investigator award at ASPET to Stephanie Piecewicz of MIT